Patient survival on the dose escalation phase of the Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG) clinical trial compared to historical controls.
Published
Conference Paper
Full Text
Duke Authors
- Bigner, Darell Doty
- Friedman, Henry Seth
- Herndon II, James Emmett
- Peters, Katherine Barnett
- Sampson, John Howard
Cited Authors
- Desjardins, A; Sampson, JH; Peters, KB; Vlahovic, G; Randazzo, D; Threatt, S; Herndon, JE; Boulton, S; Lally-Goss, D; McSherry, F; Lipp, ES; Friedman, AH; Friedman, HS; Bigner, DD; Gromeier, M
Published Date
- May 20, 2016
Published In
Volume / Issue
- 34 / 15_suppl
Start / End Page
- 2061 - 2061
Published By
Electronic International Standard Serial Number (EISSN)
- 1527-7755
International Standard Serial Number (ISSN)
- 0732-183X
Digital Object Identifier (DOI)
- 10.1200/jco.2016.34.15_suppl.2061